lots of reasons 1) it is ridiculously cheap at this level with it massive potential 2) running out of selling from.jaded n disappointed ex share holders 3) down tamper n manipulators running out of stocks to sell 4) maybe some insto are starting to see value 5) maybe the infusion sale is close 6) maybe CC sales are hitting the mark 7) maybe it's superior tech with TAVR is being recognized
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-515
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.15 |
Change
-0.250(2.40%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $181.3K | 17.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 720 | $10.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3407 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |